当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析 - 现金流量表

微芯生物

(688321)

  

流通市值:141.22亿  总市值:141.22亿
流通股本:4.08亿   总股本:4.08亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金398,607,546.28202,877,425.47724,164,341.79577,959,888.36
  收到的税费返还--1,422.661,422.66
  收到其他与经营活动有关的现金34,576,857.5611,329,491.5223,826,097.2218,400,888.75
  经营活动现金流入小计433,184,403.84214,206,916.99747,991,861.67596,362,199.77
  购买商品、接受劳务支付的现金30,769,935.7621,578,487.3832,867,832.5127,099,908.15
  支付给职工以及为职工支付的现金175,579,202.94104,212,598.19306,637,659.62236,146,171.07
  支付的各项税费15,218,658.254,774,438.9127,682,866.725,957,461.89
  支付其他与经营活动有关的现金149,558,109.3763,661,544.22304,675,225.53232,594,364.12
  经营活动现金流出小计371,125,906.32194,227,068.7671,863,584.36521,797,905.23
  经营活动产生的现金流量净额62,058,497.5219,979,848.2976,128,277.3174,564,294.54
二、投资活动产生的现金流量:
  收回投资收到的现金690,883,550.34287,592,095.641,363,159,077.381,100,043,460
  取得投资收益收到的现金5,148,176.92,573,109.4512,920,581.936,419,151.43
  处置固定资产、无形资产和其他长期资产收回的现金净额9,640.054,556.073,743.261,898.22
  投资活动现金流入小计696,041,367.29290,169,761.161,376,083,402.571,106,464,509.65
  购建固定资产、无形资产和其他长期资产支付的现金53,208,351.1217,436,780.09268,487,363.15211,351,728.49
  投资支付的现金692,756,636.68329,844,4421,403,630,203.11,175,141,663.89
  投资活动现金流出小计745,964,987.8347,281,222.091,672,117,566.251,386,493,392.38
  投资活动产生的现金流量净额-49,923,620.51-57,111,460.93-296,034,163.68-280,028,882.73
三、筹资活动产生的现金流量:
  取得借款收到的现金197,000,000125,000,000408,185,670295,000,000
  筹资活动现金流入小计197,000,000125,000,000408,185,670295,000,000
  偿还债务支付的现金87,398,743.3458,707,206.67186,359,896.68126,417,712.01
  分配股利、利润或偿付利息支付的现金12,686,146.866,609,384.127,628,241.1318,394,080.17
  支付其他与筹资活动有关的现金2,225,939.971,121,050.3718,834,709.3818,046,282.33
  筹资活动现金流出小计102,310,830.1766,437,641.14232,822,847.19162,858,074.51
  筹资活动产生的现金流量净额94,689,169.8358,562,358.86175,362,822.81132,141,925.49
四、汇率变动对现金及现金等价物的影响-77,413.06-143,302.02394,133.86-293,029.62
五、现金及现金等价物净增加额106,746,633.7821,287,444.2-44,148,929.7-73,615,692.32
  加:期初现金及现金等价物余额222,540,408.86222,540,408.86266,689,338.56266,689,338.56
  期末现金及现金等价物余额329,287,042.64243,827,853.06222,540,408.86193,073,646.24
补充资料:
  净利润29,592,228.83--114,570,600.33-
  资产减值准备--90,066,807.59-
  固定资产和投资性房地产折旧18,118,834.39-31,566,392.29-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧18,118,834.39-31,566,392.29-
  无形资产摊销15,490,652.34-25,082,317.09-
  长期待摊费用摊销1,514,295-2,462,663.39-
  处置固定资产、无形资产和其他长期资产的损失10,585.9--234.5-
  固定资产报废损失40,310.14-53,213.93-
  公允价值变动损失---106,925-
  财务费用9,683,864.89-17,729,777.63-
  投资损失10,753,345.71-21,707,957.3-
  递延所得税-1,806,179.79-16,065,729.08-
  其中:递延所得税资产减少5,476.17-550,458.73-
    递延所得税负债增加-1,811,655.96-15,515,270.35-
  存货的减少-13,773,112.15-6,285,636.69-
  经营性应收项目的减少-75,787,772.11--19,617,273.32-
  经营性应付项目的增加67,813,337.48-3,075,263.5-
  其他-935,513.86--3,370,424.87-
  现金的期末余额329,287,042.64-222,540,408.86-
  减:现金的期初余额222,540,408.86-266,689,338.56-
  现金及现金等价物的净增加额106,746,633.78--44,148,929.7-
公告日期2025-08-262025-04-262025-04-262024-10-31
审计意见(境内)标准无保留意见
TOP↑